Pioneer of the chemically functionalized glucides
NeTech Inc.



[Antiangiogenesis]
Anticancer effect of HCPS

HCPS suppresses neovascularization to promote the tumor nutrition uptake by inhibiting the activity of the vascular growth factors.
HCPS suppresses metastasis of tumor cells that is promoted by cytokines, also.




It is supposed that HCPS is applicable to diseases involving surplus angiogenesis.



Angiogenesis in tumor promotes its expansion.

  • Feeding vessels are generated by angiogenetic factors arising from tumor cells.
  • Supplying nourishment and oxygen from the generated vessels grows tumor.
  • Metastasis occurs via the vessels.


Retina injury involving surplus angiogenesis leads to losing sight.

  • Wet-AMD: age-related Macular Degeneration based on CNV (choroidal neovascularization)
  • Diabetic Macular Edema (DME)
  • Central retinal vein occlusion (CRVO)



Strategy of developing anticancer agent

Blockage of vascular endothelial growth factor (VEGF) from tumor

  • Monoclonal antibodies against VEGF/VEGF-Receptor
  • VEGF receptor tyrosine kinase inhibitor

Blockage of tumor cell invasion through angiogenesis

  • MMP (Matrix metalloproteinase) inhibitor

First priority as a drug

  • Inhibit growth signal by Antibody/aptamer to VEGF (VEGF-R)



Problem of the preceding angiogenesis inhibitors

Stable tumor cells become invasive and metastatic when the tumor is subjected to

BIBthe starvation state by inhibiting angiogenesis.

    Cancer Cell. 2009; 15(3): 220–231. Antiangiogenic therapy elicits malignant
    progression of tumors to increased local invasion and distant metastasis



Anticancer drug should have the inhibitory effect to metastasis
as well as angiogenesis.



Heparin binds various biomolecules described below.

(1) Growth factors (GFs), cytokines, chemokines

  • GFs: VEGF, FGF-1, HGF, KGF, PDGF, HB-EGF, TGF, etc., Nutritional factors, Midkine, interferon, Interleukin, TNF-alfa, chemokine


Heparin suppresses the activities of
cytokines to promote metastasis,
as well as VEGF to promote angiogenesis.


(2) ECM: Extra cellular Matrix (the invasive target of tumor cells)

  • Fibronectin, laminin, collagen, tenascin, thrombospondin

Heparin is combined with ECM, and then
blocks up tumor cell invasion and metastasis.


(3) Intercellular adhesion molecules (L-selectin、P-selectin、NCAM、PE-CAM)

Heparin is combined with the adhesion molecules,
and then inhibits to form tumors composed of
metastatic cells that have spread from the primary tumor.


(4) Virus, apolipoprotein, enzymes, a virus, protein derived from prion, annexin II, avidin, and so on.






Properties of heparin fits the strategy of antiangiogenesis and antimetastasis.
HCPS is a heparinoid to enhance the properties of heparin.


  • HCPS inhibits metastasis that is caused by tumor cells invasion into proteoglycan.
    • The graph shows that HCPS suppresses the invasion of tumor cells (3LL and B16) into proteoglycan of ECM.



  • HCPS strongly suppresses binding of tumor cell to proteoglycan.


  • Proteoglycan is an obstacle to metastasis based on tumor cell invasion.
  • HCPS suppressed that cultured cancer cells adhere to proteoglycans and then IIIIinvade it.
  • These results indicate that HCPS has a strong antimetastatic effect for tumor cells.
  •      Br J Cancer. 2002 June 5; 86(11): 1803–1812




Anti tumor effect of HCPS was proved in mouse tumor models.

  • HCPS was administrated to the rats establishing model tumor, and then effectively inhibits tumor growth and suppresses metastasis.



Inhibitory effect of tumor expansion

  • The graph below indicates the inhibitory effects of HCPS against the expansion of two type model tumors.




Inhibitory effect of metastasis

  • The tumor cells were administrated from the tail vein of mice, and then examined metastases to the lung.
  • It was observed that the metastasis of B-16 melanoma on the administration group is obviously suppressed.
  • The graph below indicates the inhibitory effects of HCPS against the metastasis of two type model tumors.
  • Br J Cancer. 2002 June 5; 86(11): 1803–1812





LinkIconHCPS